Juniperus Oxycedrus and Cupressus Arizonica Allergen Extracts Standardisation.

Exclusion Criteria

• •Subjects should not be excluded in terms of low or high sensitivity to Juniperus oxycedrus and Cupressus arizonica.
• •Subjects outside the age range.
• •Subjects who have previously received immunotherapy in the last 5 years for the treatment of asthma or rhinoconjunctivitis for the treatment of asthma or allergic rhinoconjunctivitis induced by allergens that may interfere with Juniperus oxycedrus and Cupressus arizonica extracts.
• •Subjects with significant symptoms of rhinoconjunctivitis and/or bronchial asthma in which the suspension of the systemic antihistamine treatment is contraindicated.
• •Subjects who have previously presented a severe secondary reaction during the performance of diagnostic skin tests by prick test.
• •Subjects under treatment with ß-blockers.
• •Subjects clinically unstable (acute asthma, febrile, etc.).
• •Subjects with active urticaria lesions, severe active dermographism, severe atopic dermatitis, sunburn, eczema, psoriasis lesions in the area where the prick test is performed (risk of false positives).
• •Subjects with active viral infection by herpes simplex or herpes varicella zoster in the area where the prick test is performed.
• •Subjects with any pathology in which the administration of adrenaline is contraindicated (hyperthyroidism, HTA, cardiopathy, etc.).
• •States of the subject in which he/she cannot offer cooperation and severe psychiatric disorders.
• •Pregnant women or women at risk of pregnancy and lactating women.